Hologic, Inc. to Host Investor Reception at the RSNA Trade Show


BEDFORD, Mass., Nov. 16 - Hologic, Inc. (NASDAQ:HOLX), a diversified diagnostic and medical product and device company dedicated to serving the healthcare needs of women, today announced the Company will host a meeting for members of the investment community who will be attending the RSNA (Radiological Society of North America) trade show in Chicago.

This meeting will be held on Tuesday, November 27, 2007, at McCormick Place from 8:00 - 10:00 AM (Central Time) and will include a presentation by members of Hologic's management team.

Interested participants may listen to the call (listen mode only) by dialing 866-383-8009 or 617-597-5342, password: 26433059 at 7:50 AM (Central Time) and referencing the Hologic Investor Meeting. This call is expected to last approximately thirty minutes. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through December 21, 2007 at 888-286-8010 or 617-801-6888 (pass code 84630973).

The Company will also provide a live webcast of the call. Interested participants may access the webcast at the Company's website at www.hologic.com. A replay of the call will be archived on the Company's website.

About Hologic, Inc.

Hologic, Inc. is a diversified diagnostic and medical product and device company dedicated to serving the healthcare needs of women. Historically, we have developed, manufactured and marketed products focused on mammography, breast care and osteoporosis assessment. In October 2007, we completed our business combination with Cytyc Corporation, a company that develops, manufactures and markets a complementary product line covering a range of cancer and women's health applications, including cervical cancer screening, treatment of excessive menstrual bleeding, and radiation treatment of early- stage breast cancer. As a result of our business combination with Cytyc, we have become one of the largest companies in the world focused on creating innovative and clinically effective advanced technologies in women's health. For more information visit www.hologic.com.

Source: Hologic, Inc

CONTACT: Glenn P. Muir, Executive Vice President and CFO, +1-781-999-7300

or Frances Crecco, Director, Investor Relations, +1-781-999-7377, both of Hologic, Inc.

Web site: www.hologic.com/

All Topics